OncoMatch/Clinical Trials/NCT03398161
Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides
Is NCT03398161 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for localized skin lesion.
This phase II trial studies how well ultra low dose radiation therapy works in treating patients with mycosis fungoides. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving ultra low doses of radiation may help control the disease and reduce side effects compared to treatment with higher doses.
Check if I qualifyExtracted eligibility criteria
Cancer type
Non-Hodgkin Lymphoma
Disease stage
Required: Stage IA, IB, IIA, IIB, III, IV, IVB
All stages of disease (IA through IVB) where radiation therapy is being considered for local control are eligible.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- M D Anderson Cancer Center · Houston, Texas
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify